Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Twitter Sign Removed From Company's San Francisco Building
The Twitter logo was removed from the company's building in San Francisco.
Skittles Partners With French's for Mustard Flavor
Skittles Partners With French's for Mustard Flavor
Observing Plastic-Free July
Plastic-Free July is being observed to highlight the use of plastic and its effects. Cheddar News' Michelle Castillo gave up using single-use plastic for the day and spoke with Kathyrn Kellogg, founder of Going Zero Waste, to get her take.
Twitter Sign Removed From Company's Building in San Francisco
Workers removed the Twitter logo from the company's building in San Francisco.
Stocks Relatively Flat Ahead of Powell Comments Wednesday
Stocks were generally flat after the market opening ahead of Fed Chair Jerome Powell's comments on Wednesday.
Be Well: How Global Events Are Impacting the U.S. Economy
Be Well: How Global Events Are Impacting the U.S. Economy
Hundreds of Flights Delayed at Phoenix Airport
Over 200 flights were delayed or canceled in Phoenix on Monday due to a telecommunications issue.
Stretching Your Dollar: Renovating Your Home on the Cheap
Stretching Your Dollar: Renovating Your Home on the Cheap
Stretching Your Dollar: How to Make Better Money Moves
Stretching Your Dollar: How to Make Better Money Moves
